Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,307,451
+$214,552 QoQ
Shares Held
13,023
+2.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#1,929
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hardy Reed LLC holds $12,890,734 across 10 Drug Manufacturers - General names. JNJ ranks #2 (25.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,509 | $4,208,800 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
13,023 | $3,307,451 | |
| 3 | ABBV |
AbbVie Inc.
|
9,616 | $2,419,770 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,034 | $903,869 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,689 | $500,660 | |
| 6 | AZN |
Astrazeneca PLC
|
2,496 | $473,291 | |
| 7 | AMGN |
Amgen Inc
|
1,129 | $408,833 | |
| 8 | NVS |
Novartis AG
|
1,440 | $225,676 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,307,451 | 13,023 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,092,899 | 12,653 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,613,364 | 12,628 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,297,353 | 12,390 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,954,436 | 12,795 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,131,541 | 12,853 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,865,742 | 12,901 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $2,011,650 | 12,413 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,793,821 | 12,273 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $853,276 | 5,394 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $673,825 | 4,299 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $877,962 | 5,637 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $872,124 | 5,269 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $832,970 | 5,374 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $949,317 | 5,374 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $877,896 | 5,374 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $953,938 | 5,374 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $903,518 | 5,098 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $849,362 | 4,965 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $624,036 | 3,864 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $659,618 | 4,004 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $659,700 | 4,014 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $634,084 | 4,029 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $599,837 | 4,029 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $483,767 | 3,440 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $453,054 | 3,455 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||